John Paulson’s Hedge Fund Opens New Bet On Calvin Klein Owner PVH With $46 Million Stake, Dumps Alphabet and Adds to Madrigal
Paulson & Co. disclosed in its Q3 13F that it opened a ~$46M PVH stake (620,820 shares), increased Madrigal Pharmaceuticals to 1.49M shares (~$751.7M), and exited Alphabet (GOOGL). It also added Warner Bros. Discovery and adjusted Thryv holdings.
How this was made

The 30-second read
Why it matters
For PVH and MDGL, the main tradable element is the direction and size of the disclosed stake change. For GOOGL, the exit is disclosed but appears small and lacks rationale, reducing conviction for a price impact.
Market read
This is a routine 13F-based positioning update. It may influence short-term sentiment and watchlists, but it does not introduce new company fundamentals.
What to watch
The article does not provide Paulson’s thesis, cost basis, or whether trades were driven by options/hedges; without that, traders may overfit the 13F headline.
Background
The piece summarizes Paulson & Co.’s third-quarter 13F changes, including new PVH exposure, an increase in MDGL, and a full exit from Alphabet.
Ticker impact
Paulson & Co. opened a new PVH position of 620,820 shares, valued at about $46 million, per its latest 13F.
Likely limited, mostly sentiment-driven reaction as traders weigh 13F signal versus lack of operational news.
The article is a routine 13F disclosure. It provides size and direction (new stake) but no new PVH-specific business development, guidance, or event.
Paulson increased its Madrigal Pharmaceuticals stake by 151,599 shares, or 11%, to 1.49 million shares, per its latest 13F.
Mild upward bias possible from positioning optics, but overall impact likely muted.
The disclosed change is directionally positive (increase) and includes updated value, yet the article contains no new MDGL trial, approval, or guidance information.
Paulson fully exited Alphabet, eliminating a 5,000-share position valued at about $1.8 million, according to its latest 13F.
No strong directional move expected; any reaction would be short-lived and sentiment-based.
The article provides an exit but not the rationale, and the position size cited is relatively small versus Alphabet’s scale.
Market effects
Limited sector read-through, since the catalyst is a hedge fund’s disclosed portfolio change rather than sector fundamentals.
None material; this is US-listed equity positioning information.
Low; no cross-market policy, macro, or global transaction details are introduced.
Counterpoint
13F changes often reflect portfolio rebalancing, tax/hedging, or timing effects, so the signal may be noisy versus fundamentals.
Key entities
- equityPVH Corp.
Calvin Klein owner; Paulson opened a new position valued at about $46 million.
- equityMadrigal Pharmaceuticals Inc.
Paulson increased its stake to 1.49 million shares, about $751.7 million at quarter-end.
- equityAlphabet Inc.
Paulson fully exited a small position, eliminating about $1.8 million of value.
- hedge_fundPaulson & Co. Inc.
Reported the portfolio changes via its latest 13F filing.





